University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Green Co-magaldrox suspension

Second line - when a lower sodium content is required. High relative cost.

Status: Amber Combigan eye drops

Specialist ophthalmologist recommendation

Status: Red Conestat Alfa (Ruconest)

NHS England commissioned. Hospital only.

Status: Green Copper intra-uterine devices

Second line - copper intra-uterine devices (72 – 120 hours)

Status: Red Corticorelin

Hospital use only

Status: Amber Cosopt eye drops

Specialist ophthalmologist recommendation

Status: Amber Cosopt eye drops (preserv free)

Specialist ophthalmologist recommendation

Status: Amber Creon®

For use in swallowing difficulties or via nasogastric tube

Status: Green Cyclizine injection

For palliative care use

Status: Amber Cyclopentolate 0.5% and 1% single dose eye drops

Specialist ophthalmologist recommendation. Use by glaucoma surgeons for neovascular glaucoma.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top